What does Decoy Therapeutics Inc. do?
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical…
What is Decoy Therapeutics Inc.'s P/E and P/B ratio?
Decoy Therapeutics Inc. has a P/E ratio of 0.1 and a P/B ratio of 0.57.
What is Decoy Therapeutics Inc.'s debt-to-equity ratio?
Decoy Therapeutics Inc. has a debt-to-equity ratio of 0.00.
How much does Decoy Therapeutics Inc. owe compared with what it owns?
Decoy Therapeutics Inc. owes $0.52 for every $1 it owns (balance sheet Jun 2026), which is moderate.
What is Decoy Therapeutics Inc.'s Positivity rank?
Decoy Therapeutics Inc. is ranked #655 of 6,774 companies globally and #106 of 4,000 in United States on PositoAI, with a Positivity Score of 23,922.
Does Decoy Therapeutics Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. Decoy Therapeutics Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 02 Jan 2026). It has no yellow flags.
Where can I read the latest news about Decoy Therapeutics Inc.?
Recent headlines about Decoy Therapeutics Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Decoy Therapeutics Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Decoy Therapeutics Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.